Anti-inflammatory, analgesic and antioxidant activities of 3,4-oxo-isopropylidene-shikimic acid
Context 3,4-Oxo-isopropylidene-shikimic acid (ISA) is an analog of shikimic acid (SA). SA is extracted from the dry fruit of Illicium verum Hook. f. (Magnoliaceae), which has been used for treating stomachaches, skin inflammation and rheumatic pain. Objective To investigate the anti-inflammatory, an...
Saved in:
Published in | Pharmaceutical biology Vol. 54; no. 10; pp. 2282 - 2287 |
---|---|
Main Authors | , , , , |
Format | Journal Article |
Language | English |
Published |
England
Taylor & Francis
02.10.2016
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | Context 3,4-Oxo-isopropylidene-shikimic acid (ISA) is an analog of shikimic acid (SA). SA is extracted from the dry fruit of Illicium verum Hook. f. (Magnoliaceae), which has been used for treating stomachaches, skin inflammation and rheumatic pain.
Objective To investigate the anti-inflammatory, analgesic and antioxidant activities of ISA.
Materials and methods Analgesic and anti-inflammatory activities of ISA were evaluated using writhing, hot plate, xylene-induced ear oedema, carrageenan-induced paw oedema and cotton pellets-induced granuloma test, meanwhile the prostaglandin E
2
(PGE
2
) and malondialdehyde (MDA) levels were assessed in the oedema paw tissue. ISA (60, 120 and 240 mg/kg in mice model and 50, 120 and 200 mg/kg in rat model) was administered orally, 30 min before induction of inflammation/pain. Additionally, ISA was administered for 12 d in rats from the day of cotton pellet implantation. The active oxygen species scavenging potencies of ISA (10
−3
-10
−5
M) were evaluated by the electron spin resonance spin-trapping technique.
Results ISA caused a reduction of inflammation induced by xylene (18.1-31.4%), carrageenan (7.8-51.0%) and cotton pellets (11.4-24.0%). Furthermore, ISA decreased the production of PGE
2
and MDA in the rat paw tissue by 1.0-15.6% and 6.3-27.6%, respectively. ISA also reduced pain induced by acetic acid (15.6-48.9%) and hot plate (10.5-28.5%). Finally, ISA exhibited moderate antioxidant activity by scavenging the superoxide radical and hydroxyl radical with IC
50
values of 0.214 and 0.450 μg/mL, respectively.
Discussion and conclusion Our findings confirmed the anti-inflammatory, analgesic and antioxidant activities of ISA. |
---|---|
AbstractList | Context 3,4-Oxo-isopropylidene-shikimic acid (ISA) is an analog of shikimic acid (SA). SA is extracted from the dry fruit of Illicium verum Hook. f. (Magnoliaceae), which has been used for treating stomachaches, skin inflammation and rheumatic pain. Objective To investigate the anti-inflammatory, analgesic and antioxidant activities of ISA. Materials and methods Analgesic and anti-inflammatory activities of ISA were evaluated using writhing, hot plate, xylene-induced ear oedema, carrageenan-induced paw oedema and cotton pellets-induced granuloma test, meanwhile the prostaglandin E2 (PGE2) and malondialdehyde (MDA) levels were assessed in the oedema paw tissue. ISA (60, 120 and 240 mg/kg in mice model and 50, 120 and 200 mg/kg in rat model) was administered orally, 30 min before induction of inflammation/pain. Additionally, ISA was administered for 12 d in rats from the day of cotton pellet implantation. The active oxygen species scavenging potencies of ISA (10(-3)-10(-5) M) were evaluated by the electron spin resonance spin-trapping technique. Results ISA caused a reduction of inflammation induced by xylene (18.1-31.4%), carrageenan (7.8-51.0%) and cotton pellets (11.4-24.0%). Furthermore, ISA decreased the production of PGE2 and MDA in the rat paw tissue by 1.0-15.6% and 6.3-27.6%, respectively. ISA also reduced pain induced by acetic acid (15.6-48.9%) and hot plate (10.5-28.5%). Finally, ISA exhibited moderate antioxidant activity by scavenging the superoxide radical and hydroxyl radical with IC50 values of 0.214 and 0.450 μg/mL, respectively. Discussion and conclusion Our findings confirmed the anti-inflammatory, analgesic and antioxidant activities of ISA. Context 3,4-Oxo-isopropylidene-shikimic acid (ISA) is an analog of shikimic acid (SA). SA is extracted from the dry fruit of Illicium verum Hook. f. (Magnoliaceae), which has been used for treating stomachaches, skin inflammation and rheumatic pain. Objective To investigate the anti-inflammatory, analgesic and antioxidant activities of ISA. Materials and methods Analgesic and anti-inflammatory activities of ISA were evaluated using writhing, hot plate, xylene-induced ear oedema, carrageenan-induced paw oedema and cotton pellets-induced granuloma test, meanwhile the prostaglandin E 2 (PGE 2 ) and malondialdehyde (MDA) levels were assessed in the oedema paw tissue. ISA (60, 120 and 240 mg/kg in mice model and 50, 120 and 200 mg/kg in rat model) was administered orally, 30 min before induction of inflammation/pain. Additionally, ISA was administered for 12 d in rats from the day of cotton pellet implantation. The active oxygen species scavenging potencies of ISA (10 −3 -10 −5 M) were evaluated by the electron spin resonance spin-trapping technique. Results ISA caused a reduction of inflammation induced by xylene (18.1-31.4%), carrageenan (7.8-51.0%) and cotton pellets (11.4-24.0%). Furthermore, ISA decreased the production of PGE 2 and MDA in the rat paw tissue by 1.0-15.6% and 6.3-27.6%, respectively. ISA also reduced pain induced by acetic acid (15.6-48.9%) and hot plate (10.5-28.5%). Finally, ISA exhibited moderate antioxidant activity by scavenging the superoxide radical and hydroxyl radical with IC 50 values of 0.214 and 0.450 μg/mL, respectively. Discussion and conclusion Our findings confirmed the anti-inflammatory, analgesic and antioxidant activities of ISA. |
Author | Sun, Jin-Yao You, Cui-Yu Xing, Jian-Feng You, Hai-Sheng Dong, Kai |
Author_xml | – sequence: 1 givenname: Jin-Yao surname: Sun fullname: Sun, Jin-Yao organization: Department of Pharmacy, The First Affiliated Hospital of Xi'an Jiaotong University – sequence: 2 givenname: Cui-Yu surname: You fullname: You, Cui-Yu organization: Department of Pharmacy, The First Affiliated Hospital of Xi'an Jiaotong University – sequence: 3 givenname: Kai surname: Dong fullname: Dong, Kai organization: School of Pharmacy, Xi'an Jiaotong University – sequence: 4 givenname: Hai-Sheng surname: You fullname: You, Hai-Sheng organization: Department of Pharmacy, The First Affiliated Hospital of Xi'an Jiaotong University – sequence: 5 givenname: Jian-Feng surname: Xing fullname: Xing, Jian-Feng email: xajdxjf@mail.xjtu.edu.cn organization: School of Pharmacy, Xi'an Jiaotong University |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/27609150$$D View this record in MEDLINE/PubMed |
BookMark | eNp9kLtOAzEQRS0EAhL4BFBKijh4_IrTgRAvCYkGastre8Gwuw72Bsjf41UCJcVopjh3ZnRGaLeLnUfoBMiMAVmcA1OKULKYUQJyBiCYlGwHHcKccywA5G6ZC4MH6ACNcn4jhAjGxD46oHNJFiDIIdKXXR9w6OrGtK3pY1pPJ6YzzYvPwZbJlepD_A6u9ImxffgMffB5EusJm3IcvyMOOS5TXK6b4HzncX4N76Ed0ja4I7RXmyb7420fo-eb66erO_zweHt_dfmALQfWY1G5SnEQ0khLLWdUEqUondekMiDEHBSvvDNUcQ-WUa6crHzFKJOCKOMYG6Ozzd7yycfK5163IVvfNKbzcZU1KFCMSaCioGKD2hRzTr7WyxRak9YaiB7c6l-3enCrt25L7nR7YlW13v2lfmUW4GIDFJ0xteYrpsbp3qybmOpkOhvysP-_Gz_8_ooT |
CitedBy_id | crossref_primary_10_1007_s11306_020_01675_1 crossref_primary_10_1080_13880209_2016_1266673 crossref_primary_10_3892_ijfn_2021_17 crossref_primary_10_1002_ejoc_202100653 crossref_primary_10_1016_j_bse_2024_104861 crossref_primary_10_1016_j_ijbiomac_2024_131995 crossref_primary_10_1021_acs_chemrev_8b00350 crossref_primary_10_1089_jir_2019_0064 crossref_primary_10_1016_S1875_5364_18_30104_3 crossref_primary_10_1016_j_bmcl_2020_127654 crossref_primary_10_3390_molecules23071659 crossref_primary_10_1021_acs_jafc_3c00283 crossref_primary_10_1016_j_molstruc_2020_129831 crossref_primary_10_1016_j_jep_2018_06_019 crossref_primary_10_1016_j_jgr_2020_05_002 crossref_primary_10_3390_ijms20030582 crossref_primary_10_1016_j_ejmcr_2024_100146 crossref_primary_10_1080_10286020_2021_1871606 crossref_primary_10_1016_j_jddst_2024_105824 crossref_primary_10_3389_fphar_2023_1265571 crossref_primary_10_1186_s42826_023_00179_y crossref_primary_10_3389_fcimb_2022_818391 crossref_primary_10_3389_fvets_2022_980271 |
Cites_doi | 10.1016/S0378-8741(99)00006-9 10.1016/j.pbb.2009.03.014 10.1248/bpb.31.1761 10.1161/ATVBAHA.110.207449 10.1016/j.canlet.2004.05.005 10.3923/ijp.2006.435.438 10.1007/s10753-012-9509-7 10.1016/j.jep.2009.02.041 10.1016/j.jep.2011.04.051 10.1016/j.freeradbiomed.2004.09.001 10.1016/j.jep.2010.05.041 10.1016/j.lfs.2005.06.002 10.1007/s11418-009-0365-1 10.1111/j.1365-2249.2008.03669.x 10.1016/0160-5402(91)90057-C 10.1016/j.mrfmmm.2010.12.016 10.1016/j.jep.2005.01.018 10.1016/j.foodchem.2010.11.025 10.1016/S0304-4165(98)00168-8 10.1016/j.jep.2010.06.040 10.1016/0891-5849(90)90131-2 10.1016/j.biocel.2006.07.001 10.1016/S0378-8741(99)00200-7 10.1016/j.jep.2004.01.010 10.1186/1476-9255-9-2 |
ContentType | Journal Article |
Copyright | 2016 Informa UK Limited, trading as Taylor & Francis Group 2016 |
Copyright_xml | – notice: 2016 Informa UK Limited, trading as Taylor & Francis Group 2016 |
DBID | CGR CUY CVF ECM EIF NPM AAYXX CITATION 7X8 |
DOI | 10.3109/13880209.2016.1153663 |
DatabaseName | Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed CrossRef MEDLINE - Academic |
DatabaseTitle | MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) CrossRef MEDLINE - Academic |
DatabaseTitleList | MEDLINE MEDLINE - Academic |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Pharmacy, Therapeutics, & Pharmacology |
EISSN | 1744-5116 |
EndPage | 2287 |
ExternalDocumentID | 10_3109_13880209_2016_1153663 27609150 1153663 |
Genre | Research Article Journal Article Comparative Study |
GrantInformation_xml | – fundername: National Natural Science Foundation of China grantid: 30973578 |
GroupedDBID | --- 00X 0R~ 0YH 123 29O 4.4 ABDBF ABPTK ACGEJ ACGFS ADCVX ADRBQ ADXPE AENEX AEYQI AFKVX AJWEG ALIIL ALMA_UNASSIGNED_HOLDINGS ARJSQ BABNJ COF CS3 DU5 EAL EAP EBD EBS EJD EMK EMOBN EPL EPT EST ESX F5P GROUPED_DOAJ H13 HZ~ J.N KTTOD M4Z ML~ O9- P2P Q~Q SV3 TFDNU TFL TFW TUS V1S ~1N 53G 5VS 7X7 8FI 8FJ AAHBH AALIY ABUWG ADBBV AFKRA ALIPV AOIJS AWYRJ BCNDV BENPR BPHCQ BVXVI CAG CCPQU CGR CUY CVF CZDIS DRXRE DWTOO ECM EIF FYUFA HMCUK HYE M44 NPM NUSFT PIMPY PQQKQ PROAC RPM TDBHL UKHRP AAYXX CITATION 7X8 |
ID | FETCH-LOGICAL-c413t-5bdb84156a6c2c4326088227f0ba1557184beda284e1c3248d6beb3236508ad33 |
IEDL.DBID | 0YH |
ISSN | 1388-0209 |
IngestDate | Fri Oct 25 02:28:27 EDT 2024 Fri Aug 23 01:33:57 EDT 2024 Sat Sep 28 08:09:00 EDT 2024 Tue Jun 13 19:49:30 EDT 2023 |
IsDoiOpenAccess | false |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 10 |
Keywords | xylene Carrageenan malondialdehyde prostaglandin E2 Illicium verum Hook.f |
Language | English |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c413t-5bdb84156a6c2c4326088227f0ba1557184beda284e1c3248d6beb3236508ad33 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
OpenAccessLink | https://www.tandfonline.com/doi/pdf/10.3109/13880209.2016.1153663?needAccess=true |
PMID | 27609150 |
PQID | 1818336125 |
PQPubID | 23479 |
PageCount | 6 |
ParticipantIDs | crossref_primary_10_3109_13880209_2016_1153663 proquest_miscellaneous_1818336125 informaworld_taylorfrancis_310_3109_13880209_2016_1153663 pubmed_primary_27609150 |
PublicationCentury | 2000 |
PublicationDate | 2016-10-02 |
PublicationDateYYYYMMDD | 2016-10-02 |
PublicationDate_xml | – month: 10 year: 2016 text: 2016-10-02 day: 02 |
PublicationDecade | 2010 |
PublicationPlace | England |
PublicationPlace_xml | – name: England |
PublicationTitle | Pharmaceutical biology |
PublicationTitleAlternate | Pharm Biol |
PublicationYear | 2016 |
Publisher | Taylor & Francis |
Publisher_xml | – name: Taylor & Francis |
References | CIT0030 Yao JC (CIT0031) 2009; 29 CIT0010 CIT0012 CIT0011 CIT0014 CIT0013 Ma Y (CIT0016) 2000; 35 CIT0018 Qin L (CIT0022) 2000; 25 CIT0017 CIT0019 Wei W (CIT0028) 2010 CIT0021 CIT0020 CIT0001 CIT0023 Luo AX (CIT0015) 2011; 5 CIT0003 CIT0025 CIT0002 CIT0024 CIT0027 CIT0004 CIT0026 CIT0007 CIT0029 Editorial Committee of Chinese Pharmacopoeia. (CIT0005) 2010 CIT0006 CIT0009 CIT0008 |
References_xml | – volume: 29 start-page: 1273 year: 2009 ident: CIT0031 publication-title: Chin J Pharm Anal contributor: fullname: Yao JC – ident: CIT0020 doi: 10.1016/S0378-8741(99)00006-9 – ident: CIT0008 doi: 10.1016/j.pbb.2009.03.014 – ident: CIT0011 doi: 10.1248/bpb.31.1761 – ident: CIT0023 doi: 10.1161/ATVBAHA.110.207449 – ident: CIT0012 doi: 10.1016/j.canlet.2004.05.005 – volume-title: Experimental methodology of pharmacology year: 2010 ident: CIT0028 contributor: fullname: Wei W – ident: CIT0025 doi: 10.3923/ijp.2006.435.438 – ident: CIT0029 doi: 10.1007/s10753-012-9509-7 – volume: 5 start-page: 966 year: 2011 ident: CIT0015 publication-title: J Med Plants Res contributor: fullname: Luo AX – volume-title: Chinese pharmacopoeia year: 2010 ident: CIT0005 contributor: fullname: Editorial Committee of Chinese Pharmacopoeia. – ident: CIT0003 doi: 10.1016/j.jep.2009.02.041 – volume: 35 start-page: 1 year: 2000 ident: CIT0016 publication-title: Acta Pharm Sin contributor: fullname: Ma Y – ident: CIT0027 doi: 10.1016/j.jep.2011.04.051 – ident: CIT0006 doi: 10.1016/j.freeradbiomed.2004.09.001 – ident: CIT0007 doi: 10.1016/j.jep.2010.05.041 – volume: 25 start-page: 370 year: 2000 ident: CIT0022 publication-title: China J Chin Mater Med contributor: fullname: Qin L – ident: CIT0004 doi: 10.1016/j.lfs.2005.06.002 – ident: CIT0024 doi: 10.1007/s11418-009-0365-1 – ident: CIT0018 doi: 10.1111/j.1365-2249.2008.03669.x – ident: CIT0021 doi: 10.1016/0160-5402(91)90057-C – ident: CIT0014 doi: 10.1016/j.mrfmmm.2010.12.016 – ident: CIT0010 doi: 10.1016/j.jep.2005.01.018 – ident: CIT0017 doi: 10.1016/j.foodchem.2010.11.025 – ident: CIT0009 doi: 10.1016/S0304-4165(98)00168-8 – ident: CIT0001 doi: 10.1016/j.jep.2010.06.040 – ident: CIT0013 doi: 10.1016/0891-5849(90)90131-2 – ident: CIT0026 doi: 10.1016/j.biocel.2006.07.001 – ident: CIT0019 doi: 10.1016/S0378-8741(99)00200-7 – ident: CIT0002 doi: 10.1016/j.jep.2004.01.010 – ident: CIT0030 doi: 10.1186/1476-9255-9-2 |
SSID | ssj0005335 |
Score | 2.2924378 |
Snippet | Context 3,4-Oxo-isopropylidene-shikimic acid (ISA) is an analog of shikimic acid (SA). SA is extracted from the dry fruit of Illicium verum Hook. f.... |
SourceID | proquest crossref pubmed informaworld |
SourceType | Aggregation Database Index Database Publisher |
StartPage | 2282 |
SubjectTerms | Acetic Acid Analgesics - pharmacology Animals Anti-Inflammatory Agents - pharmacology Antioxidants - pharmacology Carrageenan Cotton Fiber Dinoprostone - metabolism Disease Models, Animal Dose-Response Relationship, Drug Edema - chemically induced Edema - metabolism Edema - prevention & control Female Granuloma, Foreign-Body - chemically induced Granuloma, Foreign-Body - prevention & control Hot Temperature Hydroxyl Radical - chemistry Illicium verum Hook.f Indomethacin - pharmacology Male malondialdehyde Malondialdehyde - metabolism Mice, Inbred ICR Pain - etiology Pain - prevention & control prostaglandin E2 Rats, Sprague-Dawley Shikimic Acid - analogs & derivatives Shikimic Acid - pharmacology Superoxides - chemistry Time Factors xylene Xylenes |
Title | Anti-inflammatory, analgesic and antioxidant activities of 3,4-oxo-isopropylidene-shikimic acid |
URI | https://www.tandfonline.com/doi/abs/10.3109/13880209.2016.1153663 https://www.ncbi.nlm.nih.gov/pubmed/27609150 https://search.proquest.com/docview/1818336125 |
Volume | 54 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV3PT4MwFG50XrwYfzt_pSZmJ6pAgbHjYlwWE80OW6KnhkIbiQ4WYWb7732vgNPDvHggwOFBw9f2fY_2fY-Qa5-r0FOeZhrYPAQovYRJ5SiUcQVvIBXnCvOdH5-C4cR7ePab3YRFva0SY2hdCUWYuRoHdyRNBRLUsbx1UMDEtTHNxAlgzPsc3OYm2XK74P2hS9svw9UuD25qbKIJQ5sqiWf9Y365p1_ipespqHFFg12yU3NI2q9A3yMbKtsnnVElQr206HiVU1VYtENHK3nq5QER_axMGbwT-sLUrLFbNMqw3AcABlcJHIDWIk3gTDHv4dOortJcU255LF_kLC1yaOVs-Y4lSRUrXtO3dIrWcZocksngfnw3ZHWZBRaDByuZLxMZYhwXBbEbe8DnkHa7XW3LCNgGOC9PqiQCP6acGPhXmAQSQnCXI7mLEs6PSCvLM3VCqA5tFfs-zBJehLgDfQuljh0MK7mn4za5ab6umFVqGgKiEIRDNHAIhEPUcLRJ7ycGojS_MXRVcwTt_rS9agATMGZwISTKVD4vBLCakHPkdm1yXCH53Ry3GwCF8u3Tf7z5jGzjrdnz556TVvkxVxfAXUp5aXrnF6_L4uo |
link.rule.ids | 315,783,787,27514,27936,27937,59471,59472 |
linkProvider | Taylor & Francis |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV09T8MwELWgDLAgvimfRkJMNU1iJ01HhEAFWsRQpDJZcWKLCJpUNEX033PntJQOZWGIEim6OMqzfe9i3ztCzn2uQ6GFYQbYPAQozYQp7WqUcQVvoDTnGvOdO49B61nc9_zer1wY3FaJMbQphSLsXI2DG39G122I6TTrLiqYeA7mmbgBDHqfg99cJit-UzSwioHz0ppt8-C2yCaaMLQps3gWP2bOP82ply7moNYX3W6Q9QmJpFcl6ptkSWdb5OKpVKEe12h3llQ1rNEL-jTTpx5vE3mVFSmDNqEz9O0ie41GGdb7AMTgKoED4PpKEzhTTHz4tLKrNDeU1wTLv3KWDnN4y8H4HWuSajZ8Td_SPlrHabJDnm9vutctNqmzwGJwYQXzVaJCDOSiIPZiAYQOebfXMI6KgG6A9xJKJxE4Mu3GQMDCJFAQg3sc2V2UcL5LKlme6X1CTejo2PdhmhARAg_8LVQmdjGu5MLEVXI5_bpyUMppSAhDEA45hUMiHHICR5U0f2MgC_sfw5RFR9DuT9uzKWASBg2uhESZzkdDCbQm5BzJXZXslUj-vI7XCIBD-c7BP1o-Jautbqct23ePD4dkDW_ZDYDeEakUHyN9DESmUCe2p34DCsfmWg |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV3NS8MwFA86QbyI387PCLLT4tqm7bqjqGN-ssMGegpNk2BR22GruP_e99LN6UEvHkoL5bWhvyTv95q83yPkOOA68rVvmAE2DwFKRzGpXY0yruANpOZcY77z7V3YG_pX98F0N2Ex2VaJMbSphCLsXI2De6RMy0aYTqflooCJ52CaiRvCmA84uM15shB0YKaFLu089Ga7PLitsYkmDG2qJJ7fH_PDPf0QL_2dglpX1F0hyxMOSU8r0FfJnM7WSKNfiVCPm3Qwy6kqmrRB-zN56vE6EadZmTJ4J_SFF7vG3qRxhuU-ADC4UnAAWh-pgjPFvId3q7pKc0N502f5R87SIodWjsbPWJJUs-IxfUpf0DpJ1QYZdi8GZz02KbPAEvBgJQukkhHGcXGYeIkPfA5pt9c2joyBbYDz8qVWMfgx7SbAvyIVSgjBPY7kLlacb5Jalmd6m1ATOToJApgl_BhxB_oWSZO4GFZy3yR1cjL9umJUqWkIiEIQDjGFQyAcYgJHnXS-YyBK-xvDVDVH0O5P26MpYALGDC6ExJnO3woBrCbiHLldnWxVSH41x2uHQKECZ-cfbz4ki_3zrri5vLveJUt4x27_8_ZIrXx90_tAY0p5YDvqJ6ff5YM |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Anti-inflammatory%2C+analgesic+and+antioxidant+activities+of+3%2C4-oxo-isopropylidene-shikimic+acid&rft.jtitle=Pharmaceutical+biology&rft.au=Sun%2C+Jin-Yao&rft.au=You%2C+Cui-Yu&rft.au=Dong%2C+Kai&rft.au=You%2C+Hai-Sheng&rft.date=2016-10-02&rft.eissn=1744-5116&rft.volume=54&rft.issue=10&rft.spage=2282&rft.epage=2287&rft_id=info:doi/10.3109%2F13880209.2016.1153663&rft.externalDBID=NO_FULL_TEXT |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1388-0209&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1388-0209&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1388-0209&client=summon |